OOIR: Observatory of International Research

Papers

(The H4-Index of Bioorganic & Medicinal Chemistry Letters is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Design, synthesis and biological evaluation of tanshinone IIA derivatives as NLRP3 inflammasome inhibitors	107
Editorial Board	73
Pyrazolo-1-carbothioamides as EGR-1–DNA binding disruptors	54
Design, synthesis and characterizations of prodrugs of brexanolone	52
Discovery of TNG-6132, a potent, selective, and orally bioavailable USP1 inhibitor	50
Armeniaspirol analogues disrupt the electrical potential (ΔΨ) of the proton motive force	42
Editorial Board	37
Graphical Abstract TOC	37
Neuropilin 1-targeted near-infrared fluorescence probes for tumor diagnosis	33
Contents continued	33
Synthesis and biological evaluation of novel 1,2,3,4-tetrahydro-β-carboline derivatives as potential antibacterial agents	32
Design, synthesis and biological evaluation of alginate oligosaccharide derivatives	30
Design and evaluation of anaplastic lymphoma kinase degraders using a covalent fumarate handle	29
Studies on in vitro modulatory effects to base excision repair enzymes induced by small molecule binding to Deaminated CAG repeat hairpin	29
Enteroviral replication inhibition by N-Alkyl triazolopyrimidinone derivatives through a non-capsid binding mode	28
Design and synthesis of Tetrahydroindeno[4,5-c]chromen-4(3H)-one derivatives as antiproliferative agents for prostate Cancer cells	27
Discovery of multitargeting single agents as a novel route to the potential treatment of neurodegenerative diseases	27
Phytochemical investigation of Asarum sieboldii var. seoulense and the phenotypic profiles of its constituents against a Parkinson’s Disease olfactory cell line	26
Discovery of DS-1093a: An oral hypoxia-inducible factor prolyl hydroxylase inhibitor for the treatment of renal anemia	26
SARS-CoV-2 papain-like protease (PLpro) inhibitory and antiviral activity of small molecule derivatives for drug leads	26
Epigallocatechin and epigallocatechin-3-gallate are not inhibitors of tyrosinase	25
Improved synthesis and anticancer activity of a potent neuronal nitric oxide synthase inhibitor	24
Revisiting the dipeptidyl carboxypeptidase inhibitor captopril as a source of pan anti-trypanosomatid agents	24
Green synthesis and anti-biofilm activities of 3,5-disubstituted isoxazoline/isoxazole-linked secondary sulfonamide derivatives on Pseudomonas aeruginosa	24